Trials / Conditions / Acquired Pure Red Cell Aplasia
Acquired Pure Red Cell Aplasia
3 registered clinical trials studyying Acquired Pure Red Cell Aplasia — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Linperlisib in the Treatment of aPRCA NCT07031115 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophospham NCT06412497 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment NCT04423367 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |